blue cross blue shield cover tirzepatide GLP-1 Drugs Could Raise Employer Health Premiums Alternatives to GLP-1 medication?

Semaglutide can reduce appetite and support weight loss, but diet quality still matters for sustainable results

Diagnostic approach ABCDE survey Targeted clinical evaluation 12-lead ECG CBC: Initial Hb/Hct may not reflect the degree of acute hemorrhage

Studies suggest that in diet-induced insulin-resistant rodents, insulin-mediated skeletal muscle microvascular blood flow is impaired post-short-term high fat feeding, and this occurs before the development of myocyte or whole-body insulin resistance

Innovation race:Both companies are investing billions in research and development to outpace each other

Some studies link GLP-1 use to an increased risk for eye diseases but a recent paper argues there is insufficient evidence to suggest drugs like Ozempic contribute to vision loss.